Table 1 |
|
|
Main clinical and laboratory features of 29 patients with systemic sclerosis (SSc) |
|
|
Gender (male/female) |
1/28 |
|
|
|
|
Age (mean ± SD) |
56.3 ± 12.9 |
|
|
|
|
SSc type (limited/diffuse) |
22/7 |
|
|
|
|
Duration of disease (median, months) |
42 (1 - 390) |
|
|
|
|
Raynaud phenomenon (no/yes) |
0/29 |
|
|
|
|
MRSS (median) |
7 (2 - 24) |
|
|
|
|
Renal involvement (no/yes) |
26/3 |
|
|
|
|
Lung involvement (no/yes) |
21/8 |
|
|
|
|
Oesophagus involvement (no/yes) |
20/9 |
|
|
|
|
Antinuclear antibodies on HEp-2 cell line (negative/anti-centromere/anti-topoisomerase I) |
7/16/6 |
|
|
|
|
MRSS, modified Rodnan skin score. |
|
|
Gambichler et al. European Journal of Medical Research 2010 15:44 doi:10.1186/2047-783X-15-1-44 |
|
